Literature DB >> 9155707

Do HPV-negative cervical carcinomas exist?

J M Walboomers, C J Meijer.   

Abstract

Based on improvements in HPV detection technology, it appears that an almost 100% HPV association is reached for cervical cancer, as demonstrated in an accompanying paper in this issue of the Journal. Factors which may explain the rare cases in which no HPV DNA is detectable include: improper sampling; disruption of HPV by integration events; the existence of still unidentified HPVs; sensitivity of the method; and the mechanism of transformation. Finally, epidemiological studies identifying HPV independent risk factors are necessary to answer the question of whether HPV independent pathways exist for cervical carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155707     DOI: 10.1002/(SICI)1096-9896(199703)181:3<253::AID-PATH755>3.0.CO;2-0

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  29 in total

1.  Human papillomavirus and pterygium. Is the virus a risk factor?

Authors:  Nicolai Christian Sjö; Christian von Buchwald; Jan Ulrik Prause; Bodil Norrild; Troels Vinding; Steffen Heegaard
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

2.  Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection.

Authors:  E L Franco; E Duarte-Franco; A Ferenczy
Journal:  CMAJ       Date:  2001-04-03       Impact factor: 8.262

3.  Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.

Authors:  Anna Söderlund-Strand; Per Rymark; Pia Andersson; Joakim Dillner; Lena Dillner
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 4.  HPV vaccine: Current status and future directions.

Authors:  Sushil Kumar; Manash Biswas; Tony Jose
Journal:  Med J Armed Forces India       Date:  2015-03-13

5.  Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on HIV status.

Authors:  Akiko Kobayashi; Teresa Darragh; Brian Herndier; Kathryn Anastos; Howard Minkoff; Mardge Cohen; Mary Young; Alexandra Levine; Linda Ahdieh Grant; William Hyun; Vivian Weinberg; Ruth Greenblatt; Karen Smith-McCune
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

6.  Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers.

Authors:  M Yoshinouchi; A Hongo; K Nakamura; J Kodama; S Itoh; H Sakai; T Kudo
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

7.  Analysis of human papillomavirus E7 protein status in C-33A cervical cancer cells.

Authors:  Andreas Kaiser; Brigitte Jenewein; Haymo Pircher; Ursula Rostek; Pidder Jansen-Dürr; Werner Zwerschke
Journal:  Virus Genes       Date:  2014-10-19       Impact factor: 2.332

8.  Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.

Authors:  Dohun Pyeon; Michael A Newton; Paul F Lambert; Johan A den Boon; Srikumar Sengupta; Carmen J Marsit; Craig D Woodworth; Joseph P Connor; Thomas H Haugen; Elaine M Smith; Karl T Kelsey; Lubomir P Turek; Paul Ahlquist
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

Review 9.  Molecular events in uterine cervical cancer.

Authors:  S A Southern; C S Herrington
Journal:  Sex Transm Infect       Date:  1998-04       Impact factor: 3.519

Review 10.  Human papillomavirus and cervical cancer.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.